Common Causes of Low Quality in Pharmaceuticals

  • Home
  • Common Causes of Low Quality in Pharmaceuticals

Common Causes of Low Quality in Pharmaceuticals

Common Causes of Low Quality in Pharmaceuticals

Maintaining pharmaceutical quality is critical to ensure safety, efficacy, and regulatory compliance. Low-quality medicines can arise from multiple factors across raw materials, manufacturing, storage, and distribution.


1. Raw Material-Related Causes

  • Use of substandard or contaminated APIs.

  • Poor quality or improperly tested excipients.

  • Variability in raw material suppliers without proper qualification.

  • Lack of proper incoming material testing and sampling.


2. Manufacturing Process Causes

  • Improper mixing, blending, or granulation, leading to non-uniform drug content.

  • Incorrect process parameters (temperature, pressure, coating, drying).

  • Cross-contamination between products or batches.

  • Use of unqualified equipment or poor calibration/maintenance.

  • Inadequate in-process controls during manufacturing.


3. Personnel-Related Causes

  • Lack of proper training in GMP (Good Manufacturing Practices).

  • Negligence or non-compliance with SOPs.

  • Human errors in documentation, weighing, or labeling.

  • Insufficient staffing in quality-critical areas.


4. Quality Control / Quality Assurance Issues

  • Incomplete or incorrect testing of raw materials, intermediates, and finished products.

  • Failure to validate analytical methods.

  • Weak investigation systems for OOS (Out of Specification) or OOT (Out of Trend) results.

  • Poor documentation practices (data integrity failures).


5. Packaging and Storage Causes

  • Use of inappropriate packaging materials (leads to degradation).

  • Poor sealing or labeling errors.

  • Improper storage conditions (temperature, humidity, light exposure).

  • Absence of stability studies or ignoring shelf-life recommendations.


6. Distribution and Supply Chain Issues

  • Temperature excursions during transportation (cold chain failures).

  • Counterfeit or falsified products entering supply chain.

  • Improper handling by distributors or pharmacies.


7. Regulatory and Systemic Failures

  • Weak internal audits and lack of continuous improvement.

  • Non-compliance with GMP / GLP / GCP regulations.

  • Pressure for cost reduction leading to compromise in quality.

  • Lack of robust CAPA (Corrective and Preventive Actions) after deviations.


In summary:
Low pharmaceutical quality often arises due to poor raw materials, inadequate manufacturing controls, human errors, weak QA/QC, poor packaging/storage, and regulatory lapses. A strong Quality Management System (QMS) with robust GMP practices is essential to prevent such failures.

🎓 Discover one of the best Complete Pharmaceutical Production Course available —click below to explore the course that’s shaping future Production Course skills.

https://trcjw.on-app.in/app/oc/338669/trcjw

Submit a Comment

Your email address will not be published. Required fields are marked *


The reCAPTCHA verification period has expired. Please reload the page.

Hello
Chat now via Whatsapp